Share Name Share Symbol Market Type Share ISIN Share Description
Shire Plc LSE:SHP London Ordinary Share JE00B2QKY057 ORD 5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +102.00p +2.36% 4,432.50p 4,437.50p 4,439.00p 4,482.50p 4,344.50p 4,345.00p 2,551,804.00 16:35:01
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 4,354.9 940.5 149.8 25.3 26,268.05

Shire Share Discussion Threads

Showing 1951 to 1971 of 1975 messages
Chat Pages: 79  78  77  76  75  74  73  72  71  70  69  68  Older
DateSubjectAuthorDiscuss
08/12/2016
09:58
Potential for decent spikes here, but chart is on a downward trendTrump tweets don't help
mbmiah
08/12/2016
09:20
Trumpie has plans for profit gougers..
bulltradept
07/12/2016
16:39
Unencrypted Trump twitters make for feral equities.
steeplejack
07/12/2016
14:03
Looking interesting again
mbmiah
03/12/2016
21:04
Potential reaction of Shire (SHP) to analyst' perspective on its shares ( http://crweworld.com/article/markets/48005/analysts-viewpoints-atlassian-team-transocean-rig-shire-shpg-square-sq-genvec-gnvc-legal-general-group-lggny ) plus the topline data from VONVENDI trial ( http://crweworld.com/article/press-releases/48006/topline-results-of-phase-3-investigational-study-of-vonvenditm-von-willebrand-factor-recombinant-meets-primary-endpoint-effectively-controlling-bleeding-and-blood-loss-during-surgical-procedures )
arnu gutierrez
10/11/2016
10:06
Sold, £6 per share up minus costs.
philo124
09/11/2016
09:25
Got the timing right on the buy back at the mo.
philo124
09/11/2016
08:51
20% upside now Obamacare is out of the way
bigboots
07/11/2016
12:19
Bought back in this morning hoping to see £52 in due course.
philo124
01/11/2016
16:01
http://www.telegraph.co.uk/business/2016/11/01/shire-in-fine-form-and-will-shrug-off-pricing-pressure-says-chie/
zho
20/10/2016
00:13
............. Re Cancer drugs , proteomics and genomics ................. I choose them because they are where the money is at If you do some research you will find that many celebrities have undergone surgery to remove various parts of their body in order to avoid the onset of a cancer type. They have done this because they have tested positive for an inherited genetic mutated gene which recent molecular diagnostic testing has proved to be linked to certain cancer types and subsets. Thus since we all know at present no cure for any cancer using drugs exists Then this also proves that the continued development of drugs which target tumors is a waste of time re finding a cure. However some new drugs do extend life by several months eg circa from 12 months to perhaps eighteen months The quality of this extended life does not get mentioned much My point is that the rich celebrities spend money on cancer preventative operations because they have the money and specialist guidance to do so. A cure for cancer will not be found by trying to attack a developed tumor The cure will be to attack and remove the mutated genes that cause it
buywell3
20/9/2016
13:18
Forming a nice channel
hedley03
20/9/2016
10:16
Nice move up.
philo124
01/9/2016
10:16
Topped up for eventual bid.
philo124
30/8/2016
07:23
Couple of negative influences.Firstly,Hilary Clinton overhangs the pharma sector.Secondly,the interference of the EU in sovereign tax management of Ireland (Apple) could have disturbing long term implications.Other than that,Shire looks cheap and has recovered sharply in the last couple of months being a beneficiary of weaker sterling.Additionally, stock indigestion post the Baxalta deal has dissipated.
steeplejack
29/8/2016
17:22
New Opportunity for Shire (SHP). Its Xiidra 5% for the Treatment of both the Signs and Symptoms of Dry Eye Disease is Now Available in U.S. http://crweworld.com/article/press-releases/37145/shires-first-prescription-eye-drop-xiidratm-lifitegrast-ophthalmic-solution-5-is-now-available-in-the-us
arnu gutierrez
28/8/2016
18:13
Can someone who understands this sector better than me help me with this company's valuation? I invest purely on fundamentals and look at shire trading on 12.6x Dec-17 and struggle to understand why a company which has delivered strong growth historically and will generate significant synergies from its recent mega-deal ($700m synegies, so putting them on a PE on say 15x gives $10bn value upside from them) isn't being more highly valued by Mr Market. All views welcome!
adamb1978
03/8/2016
07:59
SHIRE'S chief executive Dr Flemming Ornskov said the company's long-term goal of generating $20bn (£15bn) of sales by 2020 was "rock solid" as he upgraded profit forecasts in the company's first set of results since completing a $32bn merger with Baxalta.
steeplejack
13/7/2016
16:47
http://www.telegraph.co.uk/business/2016/07/13/shire-set-for-eye-watering-sales-after-key-ophthalmology-drug-wi/
zho
01/7/2016
11:30
$ Strength. Bought on Tuesday.
philo124
30/6/2016
09:57
Cheap £
burkedavid
Chat Pages: 79  78  77  76  75  74  73  72  71  70  69  68  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:41 V: D:20161210 01:13:07